Skip to main content

Table 2 HS-CRP

From: Evaluation of Mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study

Group Baseline 8 weeks Change
Placebo 13.10 ± 5.2 14.00 ± 8.5 + 0.90 ± 9.5
6 oz Xango 21.30 ± 16.8 14.65 ± 8.8 - 6.65 ± 11.7
12 oz Xango 18.33 ± 9.0 11.67 ± 4.2 - 6.66 ± 5.8
18 oz Xango 12.00 ± 5.6 10.67 ± 5.6 -1.33 ± 3.0
  1. Mean HS-CRP levels plus/minus standard deviations at baseline, after 8 weeks and the change over time. None of the changes from baseline were statistically significant. However the comparison of change from baseline to 8 weeks between the 18 oz group and the placebo group was significant (p = 0.019).